242950 ⎘
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof; Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products Fused cells, e.g. hybridoma
Treatment and Prophylaxis of Amyloidosis
#2Treatment and Prophylaxis of Amyloidosis
#3TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#4POLYNUCLEOTIDES ENCODING MONOCLONAL ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F
#5Treating inflammation with IL-17/IL-23 bispecific antibodies
#6Use of an IL-17/IL-23 bispecific antibody for treating inflammation
#7Monoclonal antibodies that bind both IL-17A and IL-17F
#8Polynucleotides encoding antagonists of IL-17A, IL-17F, and IL-23p19
#9Compositions and methods for diagnosing and treating cancer
#10Methods of treating inflammatory diseases using antibodies that bind both IL-17A and IL-17F
#11Antibodies that bind the glutamate ligand binding region of NOTCH3
#12Antagonists of IL-17A, IL-17F, and IL-23P19
#13Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
#14Anti-CD80 antibody
#15Nucleic acids encoding engineered anti-IL-23R antibodies
#16Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
#17TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#18Methods of using antibodies that bind the glutamate ligand binding region of Notch1
#19Antagonists of IL-17A, IL-17F, and IL-23P19
#20Anti-human IL-21 antibodies
#21Methods of treatment using anti-human IL-21 monoclonal antibodies
#22Detection of amyloid deposits using anti-amyloid antibodies
#23Anti-human IL-21 monoclonal antibodies
#24Methods of producing anti-IL-22RA antibodies
#25Engineered anti-IL-23R antibodies
#26Anti-CD86 antibody
#27Anti-amyloid antibodies
#28TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#29Chimeric, humanized, or human antibody 2A4
#30IL-21 antagonists
#31Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19
#32Anti-human IL-21 monoclonal antibodies
#33Methods for treating disease using an anti-IL-21 receptor antibody
#34Treatment and prophylaxis of amyloidosis
#35NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF
#36Antibodies that bind both IL-17A and IL-17F
#37Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
#38Antibodies to alpha-synuclein
#39Anti-histone H1 monoclonal antibody and hybridoma for the production thereof
#40Engineered anti-IL-23R antibodies
#41Transferrin receptor antibodies
#42Use of anti-IL-20 antibody for treating stroke
#43Antibodies against human IL17 and uses thereof
#44Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins
#45Anti-human IL-21 monoclonal antibodies
#46Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the Same
#47METHODS FOR TREATING DISEASE USING AN ANTI-IL-21 RECEPTOR ANTIBODY
#48Methods of treatment using anti-IL-22RA antibodies
#49Nogo receptor antagonists
#50Chimeric, humanized, or human antibody 2A4
#51Methods for detecting the presence of mutant mammalian presenilin protein
#52Anti-human IL-21 monoclonal antibodies
#53IL-21 antagonists
#54Antibodies that bind the glutamate ligand binding region of Notch1
#55Antibodies that bind both IL-17A and IL-17F and methods of using the same
#56Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
#57Polypeptide that binds anti-histone H1 antibody
#58Antibody specific for mutant presenilin 2 and method of use thereof
#59Recombinant antibodies for the detection and neutralization of anthrax toxin
#60IL-32 monoclonal antibodies and uses thereof
#61Anti-CD20 antibodies
#62Neoplasm specific antibodies and uses thereof
#63CD86 and CD80 receptor competition assays
#64Development of human monoclonal antibodies and uses thereof
#65Diagnosis and treatment of hepatic disorders
#66Antibodies to IL-21 receptor
#67IL-21 ANTAGONISTS
#68Development of human monoclonal antibodies and uses thereof
#69Diagnosis and treatment of hepatic disorders
#70Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
#71Human IgM antibody lysing activated lymphocytes under mediation by homologous complement
#72Anti-HGF-R antibodies and their use
#73Rapamycin conjugates and antibodies
#74Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of
#75Neoplasm specific antibodies and uses thereof
#76Transferrin receptor antibodies
#77Nogo receptor antagonists
#78Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
#79Antibody specific for mutant presenilin 1
#80Methods of using antibodies to detect alpha-synuclein in fluid samples
#81Therapeutic application of chimeric and radiolabeled antibodies to human B Lymphocyte restricted differentiation antigen for treatment of B cell Lymphoma
#82Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor
#83Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
#84Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same
#85Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates
#86Serum paraoxonase
#87Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs